Home | Infections | Hepatitis


UBC develops test to ensure effectiveness of new hep C drug

Associate Professor Richard Harrigan leads effort to screen for drug-resistant form of the disease ...

UNC researchers discover how Hepatitis C virus persists for years

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as ...

New research findings may lead to better treatment plans for HIV patients coinfected with hepatitis C

By Sathya Achia Abraham - Using a combination antiretroviral therapy to treat HIV patients coinfected with the hepatitis C virus (HCV) not only effectively treats HIV, but also results in reduced HCV replication, according to a multi-center study published this week in Science Translational Medicine. ... Full story

WHO welcomes global momentum on viral hepatitis

MELBOURNE/GENEVA - On World Hepatitis Day, 28 July, WHO welcomes new progress in tackling one of the world’s most serious diseases. Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E – affects millions of people worldwide, causing acute and chronic liver disease and killing close to 1.4 million people every year. ... Full story

Internal Structure of Hepatitis B Revealed for First Time

Madison, Wisconsin - Nearly 12,000 photographs and some sophisticated mathematical modeling have led a two-university research team to come up with a picture of a virus that infects millions of people worldwide and kills many in the Third World. ... Full story

Drug Treatment Programs Play Important Role in Educating, Treating Patients with Hepatitis C

People who inject drugs and are enrolled in a drug treatment program are open to receiving education and treatment for hepatitis C, according to new research by investigators at several institutions, including Weill Cornell Medical College. ... Full story

Hepatitis C may help transplant patients adapt to new liver

Transplant patients can develop tolerance to new livers even if they have hepatitis C, according to a new study led by King’s College London and the University of Barcelona. Contrary to what was previously thought, infected patients are not at greater risk of organ rejection and their heightened immune response may actually help the body to adapt to a new liver. ... Full story

1 2 3 4 5 next total: 45 | displaying: 1 - 10